Bookmark and Share

Lawrence W Adler
 

Lawrence W Adler M.D.

Academic Title: Clinical Assistant Professor
Primary Appointment: Psychiatry
ladler@psych.umaryland.edu
Location: 22 S. Greene St., S12A08
Phone: (410) 328-6637
Phone: (443) 621-6733
Fax: (410) 328-2672

Personal History:

Education

  • B.S., 9/67-6/71, University of Maryland, College Park, Biochemistry
  • M.D., 9/71-12/75, University of Maryland School of Medicine
  • Certificate of Graduate Studies, 2007, Business of Medicine, Carey Business School, Johns Hopkins University

Post Graduate Education and Training

  • Post-doctoral Research Associate, 12/75-7/76, University of Maryland School of Medicine, Dept. of Biological Chemistry
  • Residency in Psychiatry, 7/76-6/79, Sheppard-Pratt Hospital

Certifications

  • Psychiatry, American Board of Psychiatry and Neurology, 1983, #25039
  • Geriatric Psychiatry, American Board of Psychiatry and Neurology, April 1991-December 2001, December 2001-December 2011, #004
  • Clinical Psychopharmacology, American Society of Clinical Psychopharmacology,November 1998-May 2009
  • Certified Physician Investigator, Association of Pharmaceutical Physicians and Investigators, November 2002-ongoing

Research Interests:

  • Clinical psychopharmacology
  • Clinical research
  • Public Health
  • Epidemiology and genetics of psychiatric illness

Clinical Speciality:

  • Clinical psyschopharmacology
  • Geriatric psychiatry

Publications:

Peer-Reviewed Journals

Klein, D.F.#, Thase, M.E., Endicott, J., Adler, L., Glick, I., Kalali, A., Leventer, S., Mattes, J., Ross, P., Bystristsky, A. Improving Clinical Trials: American Society of Clinical Psychopharmacology Recommendations. Archives of General Psychiatry, 2002 March; 59(3): 272-8.

Hertzman, M, Adler, L.W.# , Arlen, B, Kern, M. Lisinopril May Augment Antidepressant Response. Journal of Clinical Psychopharmacology, 25(2005) 618-620

Keefe RSE.#, Bilder RM, Harvey, PD, Davis, SM, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Miller, DD, Canive, JM, Adler, LW, Mansschreck, TC, Swartz, M, Rosenheck, R, Perkins, DO, Walker, TM, Stroup TS, McEvoy, JP, Lieberman, JA. Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial. Neuropsychopharmacology, advanced online publication 19 April 2006, 1-14.

Books and Book Chapters

Hertzman M & Adler LW (2010) Clinical Trials in Psychopharmacology: A Better Brain 2nd edn. Wiley Press. West Sussex.

Adler LW (2010) "Genes, The Genome and Brain Tailored Drugs"; In: Hertzman M & Adler LW (2010) Clinical Trials in Psychopharmacology: A Better Brain 2nd edn. Wiley Press. West Sussex pp.43-56.

Presentations

Adler, L.W. Alzheimer's Disease Prevention: Is Lithium Neuroprotective? Paper presented at American Association of Geriatric Psychiatry Annual Meeting, San Diego, CA, 2005.

Adler, LW.#, Zepp, H, Cerro, L. A Model for Integrating Clinical Trials in a Community Practice Setting. Presented at APA Institute for Psychiatric Services, San Diego, CA, 2005

Adler, L.W. Alzheimer's Disease: A Final Common Pathway for Genetic Risk, Vascular Risk, Mood Dysregulation and Energy Dysregulation. Presented at American Association of Geriatric Psychiatry Annual Meeting, Puerto Rico, 2006

Adler, L.W.#, Cerro L,and Zepp H. A Meta-Analysis of the Efficacy of Paroxetine vs. Placebo Utilizing the GlaxoSmithKline Clinical Trials Registry. Presented at APA Annual Meeting, Toronto,CA, 2006

Adler, L.W.#, Remission of Major Depressive Episodes on Paroxetine vs. Placebo in Elderly and Adult Subjects. Presented at American Association of Geriatric Psychiatry Annual Meeting, New Orleans, LA, 2007

Adler, L.W.#, Reducing the Medical and Financial Burden of Depressive Illness: A Plan for Improving Health Care Services. Presented at the American Psychiatric Association Annual Meeting, San Diego, CA, 2007